• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Lipid-lowering drugs show benefits in melanoma prevention

Article

Fourteen of 3,304 lovastatin recipients developed melanoma during five years of follow-up, compared to 27 of 3,301 placebo patients

Recent Videos
Related Content
What Conferences Are You Planning to Attend in Quarter 4 of 2024?

What Conferences Are You Planning to Attend in Quarter 4 of 2024?

Article
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

Podcast
Phase 3 LIBERTY-CUPID Study C Trial for Dupilumab Meets Primary, Secondary Endpoints for Chronic Spontaneous Urticaria

Phase 3 LIBERTY-CUPID Study C Trial for Dupilumab Meets Primary, Secondary Endpoints for Chronic Spontaneous Urticaria

Article
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

Podcast
Research Observe, Classify Adverse Event Profiles for Pediatric Patients Treated With JAK Inhibitors

Research Observe, Classify Adverse Event Profiles for Pediatric Patients Treated With JAK Inhibitors

Article
Nearly half of FDA-authorized AI tools may be ineffective

Nearly half of FDA-authorized AI tools may be ineffective

Article
© 2024 MJH Life Sciences

All rights reserved.